Brief: Intervacc Receives Order For Strangvac

Intervacc AB

20/07/2022 13:35

July 20 (Reuters) - Intervacc AB  IVACC.ST :
    * INTERVACC RECEIVES ORDER FOR STRANGVAC, A VACCINE AGAINST
THE
EQUINE DISEASE STRANGLES, FROM THE DECHRA PHARMACEUTICALS PLC
GROUP FOR LAUNCH IN SELECTED EUROPEAN COUNTRIES
    * RECEIVED AN ORDER FOR EQUIVALENT OF APPROXIMATELY SEK 3
MILLION
FROM DECHRA
    * ORDER, WHICH CONTAINS VACCINE VIALS FOR REGIONS INCLUDING
UK,
GERMANY AND FRANCE, IS FOR DELIVERY DURING JULY 2022 AND USED
FOR LAUNCH IN SELECTED EUROPEAN COUNTRIES.
    * ORDER CONCERNS DELIVERY OF STRANGVAC, A VACCINE AGAINST
HIGHLY
CONTAGIOUS AND SERIOUS INFECTIOUS DISEASE EQUINE STRANGLES,
WHICH IS ENDEMIC ACROSS EUROPE
    * ORDER, WHICH CONTAINS VACCINE VIALS FOR REGIONS INCLUDING
UK,
GERMANY AND FRANCE, IS FOR DELIVERY DURING JULY 2022

Source text for Eikon:  ID:nWkrbp8B97 
Further company coverage:  IVACC.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))